Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Contact lens deposits refer to the accumulation of tear film components, including proteins (such as lysozyme, lactoferrin, and albumin), lipids, and mucins, onto the surface and within the matrix of a contact lens during wear (Subbaraman et al., 2006). These biomaterials can undergo denaturation or oxidation, leading to reduced visual acuity, physical discomfort, and inflammatory responses like giant papillary conjunctivitis (Jones et al., 2003). While some proteins like lysozyme maintain antimicrobial activity when adsorbed in their native state, their denaturation can trigger immune reactions and facilitate bacterial adhesion, increasing the risk of microbial keratitis (Willcox, 2013). Management typically involves the use of surfactants and enzymatic cleaners in contact lens care solutions to remove these materials and maintain lens biocompatibility (Stapleton et al., 2008). These cleaning agents, such as poloxamers and proteolytic enzymes, target the deposits to prevent biofouling and ensure the safety of the ocular surface. Although not a single therapeutic target, the study of these deposits is crucial for developing materials with improved resistance to fouling and more effective lens care systems.
Removal of deposits via enzymatic hydrolysis of proteins, solubilization of lipids by surfactants, and oxidative disinfection.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Contact lens deposits.